Selective anticancer drugs
- 1 September 2002
- journal article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (9), 645-646
- https://doi.org/10.1038/nrc900
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- Smart drugs: Tyrosine kinase inhibitors in cancer therapyCancer Cell, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002